Family Cancer Center
Collierville, Tennessee 38119
0 studies enrolling now · 17 studies all time
What they study most
Breast Cancer, Breast Neoplasms, Carcinoma, Small Cell, Colorectal Cancer, Extensive-Stage Small Cell Lung Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Non-Hodgkin's, Melanoma, Metastases, Metastatic Breast Cancer, Neoplasm Metastasis
Studies at this site
- Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) — Completed
- Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer — Completed
- Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer — Stopped early
- Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer — Stopped early
- Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer — Stopped early
- A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer — Completed
- A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma — Completed
- Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer — Completed
- A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer — Completed
- FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only — Completed
- Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer — Completed
- Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer — Completed
- High-dose Bevacizumab in Advanced Renal Carcinoma Patients — Completed
- Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer — Status unconfirmed
- Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer — Completed
- Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer — Completed
- MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed